Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Clinical trial NCT03623373 · COMPLETED
Trial details
- NCT number
- NCT03623373
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2020-02-09
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.